SENZA.ST
Price:
$6.6
Market Cap:
$194.73M
SenzaGen AB develops, performs, and sells non-animal tests for assessing a substance's allergenicity. The company offers genomic allergen rapid detection (GARD)skin, an in vitro test to identify potential chemical skin sensitizers; GARDpotency, an in vitro add-on test to GARDskin for potency classification; GARDskin Dose-response, an in vitro test for quantitative skin sensitizing potency assessment of chemicals; and GARDair, an in vitro test for identifying chemical respiratory sensitizers, as well as GARDskin medical device, an in vitro skin sensitization testing for medical devices and solid materials. It also provides irritation and corrosion testing services. The company offers services...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2017-09-21
Stock Exchange
STO
Ticker
SENZA.ST
According to SenzaGen AB’s latest financial reports and current stock price. The company's current ROE is -20.34%. This represents a change of 302.11% compared to the average of -5.06% of the last 4 quarters.
The mean historical ROE of SenzaGen AB over the last ten years is -23.81%. The current -20.34% ROE has changed -14.54% with respect to the historical average. Over the past ten years (40 quarters), SENZA.ST's ROE was at its highest in in the June 2016 quarter at 0%. The ROE was at its lowest in in the December 2019 quarter at -26.11%.
Average
-23.81%
Median
-26.34%
Minimum
-37.43%
Maximum
-6.87%
Discovering the peaks and valleys of SenzaGen AB ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 298.10%
Maximum Annual ROE = -6.87%
Minimum Annual Increase = -150.14%
Minimum Annual ROE = -37.43%
| Year | ROE | Change |
|---|---|---|
| 2024 | -20.60% | -36.97% |
| 2023 | -32.68% | 17.69% |
| 2022 | -27.77% | -2.33% |
| 2021 | -28.43% | 12.21% |
| 2020 | -25.34% | -32.30% |
| 2019 | -37.43% | 99.92% |
| 2018 | -18.72% | 45.55% |
| 2017 | -12.86% | -52.94% |
| 2016 | -27.34% | 298.10% |
| 2015 | -6.87% | -150.14% |
The current ROE of SenzaGen AB (SENZA.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-27.02%
5-year avg
-26.97%
10-year avg
-23.81%
SenzaGen AB’s ROE is greater than iZafe Group AB (publ) (-144.42%), greater than Clinical Laserthermia Systems AB (publ) (-57.03%), greater than Enorama Pharma AB (publ) (-1477.99%), greater than Isofol Medical AB (publ) (-69.76%), greater than Initiator Pharma A/S (-82.79%), greater than Nosa Plugs AB (-32.02%), greater than Annexin Pharmaceuticals AB (publ) (-112.75%), greater than Integrum AB (publ) (-17.96%), greater than Bio-Works Technologies AB (publ) (-84.51%), greater than Q-linea AB (publ) (-243.49%),
| Company | ROE | Market cap |
|---|---|---|
| -144.42% | $188.83M | |
| -57.03% | $195.81M | |
| -1477.99% | $184.98M | |
| -69.76% | $209.28M | |
| -82.79% | $214.26M | |
| -32.02% | $126.57M | |
| -112.75% | $163.77M | |
| -17.96% | $227.64M | |
| -84.51% | $187.28M | |
| -243.49% | $155.79M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SenzaGen AB using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like SenzaGen AB or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is SenzaGen AB's ROE?
How is the ROE calculated for SenzaGen AB (SENZA.ST)?
What is the highest ROE for SenzaGen AB (SENZA.ST)?
What is the 3-year average ROE for SenzaGen AB (SENZA.ST)?
What is the 5-year average ROE for SenzaGen AB (SENZA.ST)?
How does the current ROE for SenzaGen AB (SENZA.ST) compare to its historical average?